Chennai Journal

The Acute Bacterial Skin and Skin Structure Infections Market to Grow Positively at a Significant CAGR During the Study Period (2019-2032), estimates DelveInsight

 Breaking News
  • No posts were found

The Acute Bacterial Skin and Skin Structure Infections Market to Grow Positively at a Significant CAGR During the Study Period (2019-2032), estimates DelveInsight

February 08
20:55 2023
The Acute Bacterial Skin and Skin Structure Infections Market to Grow Positively at a Significant CAGR During the Study Period (2019-2032), estimates DelveInsight

DelveInsight’s Acute Bacterial Skin and Skin Structure Infections Market Insight, Epidemiology and Market Forecast 2032 report provides current treatment practices, emerging drugs, Acute Bacterial Skin and Skin Structure Infections market share of the individual therapies, current and forecasted Acute Bacterial Skin and Skin Structure Infections market size from 2019 to 2032 segmented by seven major markets. The report also offers current Acute Bacterial Skin and Skin Structure Infections therapy algorithms, market drivers, market barriers, and unmet medical needs to curate the best of the opportunities and assesses the underlying potential of the Acute Bacterial Skin and Skin Structure Infections market.

 

Acute Bacterial Skin and Skin Structure Infections Overview

ABSSSI is defined as a bacterial infection of skin with a lesion size area of ≥ 75 cm2 (lesion size measured by the area of redness, edema or induration). ABSSSIs consist of the most frequently diagnosed skin infections worldwide.

The symptoms observed in ABSSSI are extensive cellulitis, wound infection, major cutaneous abscesses, and burn infections. There are several pathogens that lead to ABSSSIs, such as Methicillin sensitive Staphylococcus aureus (MSSA), Methicillin resistant Staphylococcus aureus (MRSA), Beta-hemolytic Streptococcus, Escherichia coli, Enterococcus faecalis, Pseudomonas aeruginosa, and others.

ABSSSIs may be either community-acquired or hospital-acquired, and the predisposing factors include trauma, chronic cutaneous lesions, preexisting skin conditions (e.g. tinea pedis), edema due to venous insufficiency, and immunosuppression. The most serious ABSSSIs which require hospitalization for parenteral antibiotic therapy are identified based on:

(1) The nature of the potential causative pathogens (e.g. their virulence and resistance patterns) and 

(2) Host factors pointing to the severity of the disease.

 

Acute Bacterial Skin and Skin Structure Infections Epidemiological Insights

As per Delvelnsight’s analysis, the total acute bacterial skin and skin structure infections Incident cases in 2017 in 7MM were found to be approximately 7,259,000, out of which the highest incident cases of this disease were observed in the United States.

 

Acute Bacterial Skin and Skin Structure Infections Treatment Market 

Management of an ABSSSI is based on a multidisciplinary approach. The first step of management of an ABSSSI is the evaluation of hemodynamic state. For hemodynamically unstable patients, resuscitation and appropriate antimicrobial coverage should begin immediately. Eradication of the causative organism, alleviation of signs and symptoms, avoidance of complications and preventing recurrences are the main goals of ABSSSI therapy. 

Treatment for ABSSSI usually includes an antimicrobial therapy, surgical drainage, and antibiotic therapy. The therapeutic approaches favored in treating skin infections include adjunctive therapies, early and appropriate empiric antibiotic therapy, wound culture with susceptibility testing and surgical drainage and debridement. Adjunctive therapies comprise daily dressing changes, use of topical solutions including non-specific antimicrobial drugs, hyperbaric oxygen treatments, debridement, and surgical interventions planned at the initiation of treatment.  

 

Promising Therapies in the Acute Bacterial Skin and Skin Structure Infections Pipeline

  • Sivextro
  • Nuzyra
  • Baxdela 
  • Dalbavancin
  • Orbactiv 
  • And others

 

Discover more about Acute Bacterial Skin and Skin Structure Infections therapies in the pipeline @ Acute Bacterial Skin and Skin Structure Infections Drugs

 

Leading Companies Working in the Acute Bacterial Skin and Skin Structure Infections Market

  • Cubist Pharmaceutical
  • Paratek Pharmaceutical
  • Menarini Group/ Melinta Therapeutics
  • Durata Therapeutics
  • The Medicine Company
  • And others

 

To understand key companies related to the ABSSSI Market, get a snapshot of the Acute Bacterial Skin and Skin Structure Infections Regulatory and Patent Analysis.

 

Scope of the Acute Bacterial Skin and Skin Structure Infections Market Report

Study Period: 2019–2032

Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), Japan]

Key Acute Bacterial Skin and Skin Structure Infections Companies: Cubist Pharmaceutical, Paratek Pharmaceutical, Menarini Group/ Melinta Therapeutics, Durata Therapeutics, The Medicine Company, and others

Key Acute Bacterial Skin and Skin Structure Infections Pipeline Therapies: Sivextro, Nuzyra, Baxdela, Dalbavancin, Orbactiv, and others

Therapeutic Assessment: Acute Bacterial Skin and Skin Structure Infections current marketed and emerging therapies

Acute Bacterial Skin and Skin Structure Infections Market Dynamics: Acute Bacterial Skin and Skin Structure Infections market drivers and barriers 

Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies

Unmet Needs, KOL’s views, Analyst’s views, Acute Bacterial Skin and Skin Structure Infections Market Access and Reimbursement

 

Table of Contents

1. Acute Bacterial Skin and Skin Structure Infections Market Key Insights

2. Acute Bacterial Skin and Skin Structure Infections Market Report Introduction

3. Acute Bacterial Skin and Skin Structure Infections Market Overview at a Glance

4. Acute Bacterial Skin and Skin Structure Infections Market Executive Summary

5. Disease Background and Overview

6. Acute Bacterial Skin and Skin Structure Infections Treatment and Management

7. Acute Bacterial Skin and Skin Structure Infections Epidemiology and Patient Population

8. Patient Journey

9. Acute Bacterial Skin and Skin Structure Infections Emerging Drugs

10. 7MM Acute Bacterial Skin and Skin Structure Infections Market Analysis

11. Acute Bacterial Skin and Skin Structure Infections Market Outlook

12. Potential of Current and Emerging Therapies

13. KOL Views

14. Acute Bacterial Skin and Skin Structure Infections Market Drivers

15. Acute Bacterial Skin and Skin Structure Infections Market Barriers

16. Unmet Needs

17. SWOT Analysis

18. Appendix

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight

 

Trending Report Offerings by DelveInsight:

  • Gender Dysphoria Market
  • Germany Healthcare Outlook Market
  • Hyperlipidemia Market
  • Mammography Devices Market
  • Dental Equipment Market
  • Adalimumab Biosimilar Market
  • Hyperlipidemia Market
  • Metastatic Cutaneous Squamous Cell Cancer Market
  • Mucopolysaccharidosis Market

 

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance. Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.

 

Contact Us

Kritika Rehani

[email protected] 

+1(919)321-6187 

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/

Related Articles